Olympus launches AI-powered emphysema screening tech

Olympus announced today that it has fully launched its AI-driven emphysema screening program, SeleCT Screening.

SeleCT Screening, powered by 4DMedical, helps identify severe emphysema patients. These patients may benefit from a clinically proven, minimally invasive procedure called bronchoscopic lung volume reduction (BLVR). Olympus offers the Spiration valve system, an endobronchial valve that may benefit patients requiring BLVR.

The Spiration valve system includes an umbrella-shaped device placed in targeted airways of the lung during a short procedure. It allows air flow to move from diseased parts of the lung to healthier parts, enabling the healthier tissue to expand. This, in turn, allows it to function more effectively. It could give patients a chance to breathe more easily and experience improvements in their quality of life.

Sign up for Blog Updates